Dassault Systems lowered it Q1 2020: the company is now expecting revenue growth in the range of 14%-17%, down from a 20-23% guidance (that includes the acquisition of Medidata). The company has suffered from weaker than expected new license and services revenues. Meanwhile, revenues of Medidata were on a “momentum and license renewals were up too.
Key questions about Capgemini’s acquisition of Altran
We continue to reflect on Capgemini’s acquisition of Altran.
Dassault makes its largest acquisition ever. Spends USD 5.8bn in cash for a clinical trial ISV, Medidata
We usually do not comment on the M&A activities of major PLM ISVs. However, Dassault Systèmes’ acquisition of Medidata, an NYC-headquartered ISV specialized in software to manage clinical trials and commercial launches, is worth a thought or two.